Novartis AG (CHIX:NOVNz)
CHF 87.96 -0.78 (-0.88%) Market Cap: 177.46 Bil Enterprise Value: 193.40 Bil PE Ratio: 11.84 PB Ratio: 4.80 GF Score: 56/100

Q4 2022 Novartis AG Earnings Call Transcript

Feb 01, 2023 / 01:00PM GMT
Release Date Price: CHF76.26 (-2.57%)
Operator

Good morning and good afternoon, and welcome to the Novartis Q4 2022 Results Release Conference Call and Live Webcast. (Operator Instructions) And the conference is being recorded. (Operator Instructions) A recording of the conference, including the Q&A session, will be available on our website shortly after the call ends.

With that, I would like to hand over to Mr. Samir Shah, Global Head of Investor Relations. Please go ahead, sir.

Samir Shah
Novartis AG - Global Head of IR

And thank you very much, operator. And thank you to everybody for participating on what is a very busy day for reporting in pharma, European pharma.

Before we start, just reading the safe harbor statement. The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. These may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. For a description of some of these factors, please refer to the company's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot